Cases & Deals

Stallergenes merges with Greer Laboratories and forms global leader in allergy immunotherapy

Clients Stallergenes SA

Jones Day advised Stallergenes, a French Euronext-listed company, in a merger with its U.S. partner Greer Laboratories, to create Ares Allergy Holdings plc, a global leader in allergy immunotherapy listed on Euronext Paris with a market capitalization of approximately €958 million (US$1.07 billion).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.